What question did this study set out to answer?

This research aims to identify and characterize new benzamide derivatives as SUCNR1 antagonists for cancer treatment.

May 10, 2026Journal of Medicinal Chemistry0 citations

Discovery and Characterization of Benzamide Derivatives as Highly Potent SUCNR1 Antagonists for Cancer Immunotherapy

ZCZhiyuan ChengHainan Provincial Academy of Agricultural Sciences JHJiacheng HeHainan Provincial Academy of Agricultural Sciences CLChangyao LiShanghai Jiao Tong University

Key Points

This research aims to identify and characterize new benzamide derivatives as SUCNR1 antagonists for cancer treatment.
Discovery of benzamide derivatives as lead candidates
Characterization of their antagonist properties
Evaluation of their effectiveness in immuno-oncology
Demonstrated high potency of benzamide derivatives as SUCNR1 antagonists
Provided evidence supporting SUCNR1 antagonism as a viable strategy in cancer immunotherapy

Abstract

as a lead candidate for targeting SUCNR1 but also provides compelling evidence for SUCNR1 antagonism as a potent therapeutic approach in immuno-oncology.

AI에게 질문

Bookmark

View Full Paper

Cite This Study

Cheng et al. (Fri,) studied this question.

synapsesocial.com/papers/6a002222c8f74e3340f9d24a https://doi.org/https://doi.org/10.1021/acs.jmedchem.5c03465

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

AI에게 질문

Bookmark

View Full Paper